Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes
Dyadic to Attend Industry Events in March
JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Dyadic, we, us, our, or the Company) (NASDAQ: DYAI), a global biotechnology company announced it has signed a...
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Dyadic to Present at Industry Events in November
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (œDyadic, œwe, œus, œour, or the œCompany) (NASDAQ: DYAI), a global biotechnology company focused on building...
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (œDyadic, œwe, œus, œour, or the œCompany) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic to Present at Industry and Investor Events in October